Voglistat GM 2mg/500mg/0.2mg Tablet SR
Marketer
Stature Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglistat GM 2mg/500mg/0.2mg Tablet SR
Diabetic patients aged 18 and above may benefit from the combined anti-diabetic medication, GlyStat-2, a 2mg/500mg/0.2mg extended-release tablet. This formulation manages blood glucose in type 2 diabetes. GlyStat-2 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuing GlyStat-2 treatment, even with controlled blood sugar, is crucial. Premature discontinuation, without medical supervision, elevates the risk of hyperglycemia, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. GlyStat-2 is one component of a comprehensive diabetes management plan, encompassing a balanced diet, physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent GlyStat-2 side effect. Learn to identify symptoms – sweating, lightheadedness, headache, tremor – and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. GlyStat-2 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions require physician consultation before commencing GlyStat-2. Pregnant or lactating individuals must consult their doctor. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.
Primary Ingredients of Voglistat GM 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Voglistat GM 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglistat GM 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglistat GM 2mg/500mg/0.2mg Extended-Release Tablets should be administered on an empty stomach.
Common Side effects of Voglistat GM 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglistat GM 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglistat GM 2mg/500mg/0.2mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Voglistat GM 2mg/500mg/0.2mg Tablet SR works:
Voglistat GM extended-release tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglistat GM 2mg/500mg/0.2mg Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Voglistat GM 2mg/500mg/0.2mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Voglistat GM 2mg/500mg/0.2mg sustained-release tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Voglistat GM 2mg/500mg/0.2mg SR tablets carries a high risk for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease are strongly advised against using this medication. Medical consultation is essential.
LiverCAUTION
Patients with liver impairment should use Voglistat GM 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Voglistat GM 2mg/500mg/0.2mg Tablet SR :
Should you forget a Voglistat GM 2mg/500mg/0.2mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglistat GM 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
3,018 People bought this recently